GENF vs. BSFA, ROQ, VAL, IXI, OCTP, FAB, APTA, EVG, PYC, and IMM
Should you be buying Genflow Biosciences stock or one of its competitors? The main competitors of Genflow Biosciences include BSF Enterprise (BSFA), Roquefort Therapeutics (ROQ), ValiRx (VAL), IXICO (IXI), Oxford Cannabinoid Technologies (OCTP), Fusion Antibodies (FAB), Aptamer Group (APTA), Evgen Pharma (EVG), Physiomics (PYC), and ImmuPharma (IMM). These companies are all part of the "biotechnology" industry.
BSF Enterprise (LON:BSFA) and Genflow Biosciences (LON:GENF) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability, risk and community ranking.
BSF Enterprise has a beta of 1.8, meaning that its share price is 80% more volatile than the S&P 500. Comparatively, Genflow Biosciences has a beta of 2.47, meaning that its share price is 147% more volatile than the S&P 500.
BSF Enterprise received 3 more outperform votes than Genflow Biosciences when rated by MarketBeat users.
In the previous week, Genflow Biosciences' average media sentiment score of 0.00 equaled BSF Enterprise'saverage media sentiment score.
Genflow Biosciences' return on equity of -35.56% beat BSF Enterprise's return on equity.
9.2% of Genflow Biosciences shares are owned by institutional investors. 60.4% of BSF Enterprise shares are owned by company insiders. Comparatively, 63.7% of Genflow Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Genflow Biosciences beats BSF Enterprise on 5 of the 8 factors compared between the two stocks.
Get Genflow Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for GENF and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GENF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genflow Biosciences Competitors List
Related Companies and Tools
